Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Redhill Biophrma ADR (NQ: RDHL ) 0.3633 -0.0073 (-1.97%) Streaming Delayed Price Updated: 3:58 PM EDT, Jul 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Redhill Biophrma ADR < Previous 1 2 3 4 5 6 7 8 9 10 Next > The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data September 21, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Cerevel Therapeutics... Via Benzinga Exposures COVID-19 Cantor Sees 'Compelling Investment Opportunity' In This Biopharma August 31, 2021 Cantor Fitzgerald has Via Benzinga The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs September 15, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) Alcon Inc. (NYSE: ALC)... Via Benzinga Exposures COVID-19 46 Biggest Movers From Yesterday September 15, 2021 Gainers Communications Systems, Inc. (NASDAQ: JCS) jumped 39.4% to close at $9.41 on Tuesday as the company declared a special dividend of $3.50 per share. Onion Global Limited... Via Benzinga Mid-Afternoon Market Update: Dow Tumbles 300 Points; Communications Systems Shares Climb September 14, 2021 Toward the end of trading Tuesday, the Dow traded down 0.87% to 34,565.88 while the NASDAQ fell 0.46% to 15,035.39. The S&P also fell, dropping 0.60% to 4,441.76. The U.S. has... Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Tuesday's Intraday Session September 14, 2021 Gainers Progenity (NASDAQ:PROG) shares increased by 17.0% to $1.1 during Tuesday's regular session. As of 12:30 EST, this security is trading at a volume of 40.5... Via Benzinga Mid-Day Market Update: FuelCell Energy Jumps After Q3 Results; RedHill Biopharma Shares Slide September 14, 2021 Midway through trading Tuesday, the Dow traded down 0.49% to 34,698.16 while the NASDAQ fell 0.05% to 15,098.38. The S&P also fell, dropping 0.24% to 4,458.05. The U.S. has... Via Benzinga Topics Stocks Exposures US Equities 36 Stocks Moving In Tuesday's Mid-Day Session September 14, 2021 Gainers FuelCell Energy, Inc. (NASDAQ: FCEL) shares jumped 26% to $7.08 after the company reported better-than-expected Q3 results. BELLUS Health Inc. (NASDAQ: BLU) shares... Via Benzinga Why RedHill Biopharma Stock Is Getting Crushed Today September 14, 2021 A clinical failure is sending shareholders to the exits this morning. Via The Motley Fool Exposures COVID-19 Mid-Morning Market Update: Markets Mostly Lower; US Annual Inflation Rate Slows to 5.3% in August September 14, 2021 Following the market opening Tuesday, the Dow traded down 0.26% to 34,778.27 while the NASDAQ rose 0.01% to 15,106.84. The S&P also fell, dropping 0.20% to 4,459.89. The U.S.... Via Benzinga Topics Stocks Exposures US Equities What's Happening With RedHill Biopharma's Stock On Tuesday? September 14, 2021 RedHill Biopharma Ltd (NASDAQ: RDHL) announced preliminary top-line data from Phase 2/3 study evaluating opaganib in hospitalized patients with severe COVID-19... Via Benzinga RedHill Biopharma To Test Its Oral Antiviral In COVID-19 Patients In South Africa September 13, 2021 Regulatory authorities in South Africa have signed off RedHill Biopharma Ltd's (NASDAQ: RDHL) Phase 2/3 study evaluating RHB-107 (upamostat) for non-... Via Benzinga Exposures COVID-19 RHB-107 P2/3 COVID-19 Study South Africa Approval September 13, 2021 RedHill Biopharma Accelerates Ongoing U.S. Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients with South African Approval The South African Health Products Regulatory... From RedHill Biopharma Ltd Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal RedHill Unveils New Movantik Data For Opioid-Induced Constipation September 07, 2021 RedHill Biopharma Ltd (NASDAQ: RDHL) has announced new Movantik (naloxegol) Phase 3 study data analyses. The three analyses included pooled data from two Phase 3... Via Benzinga RedHill Biopharma's Opaganib Demonstrates Significant Decrease of Kidney Fibrosis September 07, 2021 COVID-19 and long COVID patients are at increased risk of developing kidney damage - Opaganib significantly decreased kidney fibrosis in a preclinical in vivo model - Renal fibrosis is a progressive... From RedHill Biopharma Ltd Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal RedHill Biopharma Ltd Announces New Movantik Analyses at PAINWeek September 07, 2021 RedHill Biopharma Presents Three New Analyses of Movantik Data at PAINWeek 2021 Two new analyses of Movantik® (naloxegol) data evaluated the safety and efficacy of Movantik in a subgroup of patients... From RedHill Biopharma Ltd Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal RedHill to Present at HCW & Cantor Conferences September 02, 2021 RedHill Biopharma to Present at H.C. Wainwright Annual Global Investment and Cantor Global Healthcare Conferences TEL AVIV, ISRAEL and RALEIGH, NC / ACCESSWIRE / September 2, 2021 / RedHill Biopharma... From RedHill Biopharma Ltd Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal 12 Health Care Stocks Moving In Wednesday's After-Market Session September 01, 2021 Gainers INmune Bio (NASDAQ:INMB) shares ... Via Benzinga 55 Biggest Movers From Yesterday September 01, 2021 Gainers Unico American Corporation (NASDAQ: UNAM) shares gained 59% to close at $4.15 on Tuesday. Elys Game Technology, Corp. (NASDAQ: ELYS) rose 43% to close at $6.62 after it... Via Benzinga Why RedHill Biopharma Stock Jumped on Tuesday August 31, 2021 An analyst on Wall Street thinks the company's commercial and development pipeline has been underestimated. Via The Motley Fool 33 Stocks Moving In Tuesday's Mid-Day Session August 31, 2021 Gainers AC Immune SA (NASDAQ: ACIU) shares jumped 68.4% to $11.77. AC Immune and its collaborating partner Genentech, part of Roche Holdings, announced topline data from Phase 2... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For August 31, 2021 August 31, 2021 Upgrades For GoodRx Holdings Inc (NASDAQ:GDRX),... Via Benzinga Mid-Morning Market Update: Markets Edge Lower; Designer Brands Earnings Top Estimates August 31, 2021 Following the market opening Tuesday, the Dow traded down 0.04% to 35,387.11 while the NASDAQ fell 0.30% to 15,219.57. The S&P also fell, dropping 0.12% to 4,523.41. The U.S.... Via Benzinga Topics Stocks Exposures US Equities 18 Stocks Moving in Tuesday's Pre-Market Session August 31, 2021 Gainers Regional Health Properties Inc (NYSE: RHE) rose 50.3% to $12.49 in pre-market trading after jumping over 15% on Monday. The company, earlier during the month, reported Q2... Via Benzinga RedHill Biopharma's Oral COVID-19 Candidate Shows Preclinical Action Against Delta Variant August 26, 2021 RedHill Biopharma Ltd (NASDAQ: RDHL) has announced preliminary results of a new preclinical study for its COVID-19 treatment candidate, opaganib. Related: ... Via Benzinga Exposures COVID-19 The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO August 26, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 25) Abbvie Inc. (NYSE: ABBV)... Via Benzinga Exposures COVID-19 12 Health Care Stocks Moving In Thursday's Pre-Market Session August 26, 2021 Gainers Ascendis Pharma (NASDAQ:ASND) stock increased by 22.69% to $151.73 during Thursday's pre-market session. The company's market cap stands at $8.1 billion.... Via Benzinga Redhill Biopharma: Q2 Earnings Insights August 26, 2021 Shares of Redhill Biopharma (NASDAQ:RDHL) rose 11.1% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share decreased 250.00%... Via Benzinga RedHill Reports Second Quarter 2021 Results August 26, 2021 - Achieved record quarterly revenues of $21.5 million for Q2/2021, 4.5% increase from Q1/2021 despite challenging market conditions; Cash balance[1] of approximately $71.5 million as of June 30, 2021 -... From RedHill Biopharma Ltd Via AccessWire Topics Intellectual Property Regulatory Compliance Supply Chain Exposures COVID-19 Intellectual Property Legal RedHill Biopharma Ltd Announces RedHill's Opaganib Strong Delta Variant Inhibition August 26, 2021 RedHill Biopharma's Opaganib Demonstrates Strong Inhibition of COVID-19 Delta Variant Opaganib demonstrated strong inhibition of COVID-19 Delta variant in a human bronchial epithelial cells model,... From RedHill Biopharma Ltd Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal < Previous 1 2 3 4 5 6 7 8 9 10 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.